Professional Documents
Culture Documents
Eu GMP Annex 1 Insights by Frank Panofen Et Al
Eu GMP Annex 1 Insights by Frank Panofen Et Al
Abstract
The 2020 release of the EU GMP Annex 1 draft includes a new chapter on viable and non-viable environmental
and process monitoring. Trend analysis and its impact on the contamination control strategy is now an essential
activity referenced multiple times. There is also clear differentiation between qualification and monitoring, and
quality risk management concepts are interwoven into each section.
Introduction
In the Principle section (Section 2), the guidelines
indicate risk assessments should be performed
for each area to ensure they are optimized,
validated and qualified. Quality objectives are
set and fulfilled through the implementation of
quality assurance (QA) systems. These systems
are controlled via scientific evaluation of risks in
accordance with quality risk management (QRM)
principles. Monitoring devices provide the reliable,
actionable data necessary to support scientific
evaluation, and are best utilized as part of a
network of failsafes to prevent unforeseen events
(i.e., interventions, system deterioration) from
impacting product quality.
There are no assumptions when determining
risk. All decisions and methodology must be
justified in a document called the contamination
control strategy (CCS), referred to multiple times
throughout Annex 1. The CCS should be an
active document at all times for its continuous CRITICAL POINT OF A FILLING LINE
improvement and application.
Differentiating Terms
There are three core events for environmental contamination control in a clean area. In order to understand when
and where they occur, they must be differentiated based on purpose. The first and most obvious is monitoring,
where the potential contamination risk to your product is assessed. This can include additional testing outside of
manufacturing areas and operations to identify areas where contamination could be allowed into clean areas. But
how are clean areas designated as such? This is the role of qualification, where a classified room’s compliance
with its intended use is determined. Qualification must be performed every 6 months for Grade A and Grade B,
and every 12 months for Grade C and Grade D. Classification is where the intended use or "cleanliness" of a room
is determined, based on ISO 14644-1:2015 regulatory specifications. Classification is a step within qualification,
and employs the use of monitoring equipment to determine relevant total particle counts for comparison. Refer to
EU GMP Annex 15 for the methodology, and ISO 14644-3:2019 for the steps for testing.
Before making the choice of which monitoring equipment to use, consider that the method must not only avoid
impacting your clean area, but must also be validated to meet or exceed expectations. This is especially important
for alternatives to traditional methods (see EP 5.1.6 for more details on validating alternative methods). Validated
rapid or automated monitoring systems are encouraged by Annex 1 to expedite detection of contamination.
A frequent monitoring using a combination of methods, such as volumetric air sampling, swabs, and contact
plates are encouraged for viable contaminants. Likewise, traditional methods such as volumetric air devices
are recommended for areas with continuous sampling. Snapshots of the environment, such as data collection
performed using 100 LPM devices, are discouraged.
All microbial testing and monitoring systems should protect product quality and rapidly detect potential
contaminants in the environment and product. The surrounding environment of Grade A (often designated Grade
B) should be monitored with the same approach as Grade A. A comprehensive environmental monitoring program
for all areas includes sampling locations, monitoring frequency, monitoring method, and incubation conditions.
In essence, they are the result of many controls occurring simultaneously in the facility. Merely monitoring and
testing for its own sake does not ensure sterility.
Proper incubation conditions are necessary to identify all potential microorganisms in the environment, and if
they are not known beforehand, are found during the risk assessment. All data collected is reviewed regularly to
verify effectiveness, but the recovery of microorganisms must be demonstrated to verify the methods used for
monitoring, disinfection and such are effective. Note that different environmental conditions favor different types
of organisms (e.g., anaerobic, slow-growing, and yeasts/molds). Grade A and Grade B do not favor microbiological
detection, adding to the challenge.
1 Data Collection
Periodic
Re-evaluation
Data
Interpretation 3
Alert and action levels should be based on historical monitoring data. Qualification data may be used in lieu of
monitoring data. Scientific justification is necessary when going outside of specified norms, so documentation
of any deviations should be made in the CCS. Where there is no specified norm, also document the rationale.
Examples include the following:
Any non-conformities may impact the process and final product, necessitating their investigation. Also determine
whether entire batches may be affected and justify why or why not. Environmental and trend data is part of batch
certification (ATMPs) according to Section 10 of Annex 1. Should they occur, CAPAs require additional sampling to
determine their effectiveness.
Conclusion
A new chapter addition to the 2020 EU GMP Annex 1 draft details viable and non-viable environmental and
process monitoring to a degree not previously seen, and is made essential to the development of an effective
contamination control strategy. This documented rationale, in addition to trending and data analysis guidelines,
risk assessment, and management techniques are referenced throughout Annex 1 for various tasks pertaining
to quality assurance. These updates align with the global effort to harmonize good manufacturing practices and
bring sterile manufacturing to new heights of safety and technological advancement.
References
1. EU GMP Annex 1 Revision: Manufacture of Sterile Medicinal Products 2020 Draft
2. ISO 14644-1:2015, Cleanrooms and Associated Controlled Environments, Part 1: Classification of air cleanliness by particle concentration
3. EU GMP Annex 15: Qualification and Validation 2015 Release
4. ISO 14644-3:2019, Cleanrooms and Associated Controlled Environments, Part 3: Test Methods
5. European Pharmacopoeia, Chapter 5.1.6: Alternative Methods for Control of Microbiological Quality
BioCapt® is a registered trademark of Particle Measuring Systems, Inc. © 2020 Particle Measuring Systems. All rights reserved. Reproduction or translation of any part of this work without the permission of the copyright owner is unlawful. Requests for
permission or further information should be addressed to Particle Measuring Systems, Inc. at 1-800-238-1801. App Note 292 09.2020